Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Iron regulatory protein 1 (IRP1) is a bifunctional protein that serves as a central sensor and regulator of cellular iron homeostasis [1, 5]. In iron-replete conditions, IRP1 functions as a cytosolic aconitase (ACO1), utilizing a [4Fe-4S] iron-sulfur cluster to catalyze the conversion of citrate to isocitrate in the citric acid cycle [1, 8]. When cellular iron levels are low or in response to oxidative stress, the iron-sulfur cluster is lost, and the protein undergoes a significant conformational change to its apo-form, which acts as an RNA-binding protein [4, 5]. In this regulatory state, IRP1 binds with high affinity to iron-responsive elements (IREs) located in the untranslated regions of mRNAs encoding proteins involved in iron uptake (e.g., transferrin receptor 1), storage (e.g., ferritin), and utilization (e.g., HIF2α) [1, 6]. This binding either stabilizes the mRNA or represses its translation, thereby coordinating the cellular response to iron availability [5, 6]. Dysregulation of the IRP1 pathway is implicated in various diseases, including neurodegenerative disorders like Parkinson's and Alzheimer's, where iron-induced oxidative stress and ferroptosis play key roles [2, 15]. It is also associated with certain cancers, such as melanoma, and hematological conditions like anemia [6, 9]. While specific IRP1-targeted therapies are not yet clinically approved, the protein is a major focus for drug discovery efforts aimed at modulating iron metabolism and preventing iron-mediated cell death [2, 7]. Interactions with drugs like doxorubicin can lead to the formation of a 'null' protein state, contributing to side effects such as cardiotoxicity [4].
Post-transcriptional regulation of iron metabolism genes by binding to iron-responsive elements (IREs) in target mRNAs, which either inhibits translation or prevents mRNA degradation depending on the IRE position.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Iron regulatory protein 1 (IRP1).